MEMORIAL SLOAN KETTERING CANCER CENTER launched a new center, The Fiona and Stanley Druckenmiller Center for Lung Cancer Research.
KEVIN FITZPATRICK was named CEO of CancerLinQ LLC, a wholly owned, non-profit subsidiary of the American Society of Clinical Oncology.
The Council of the National Academy of Sciences approved the nomination of MARCIA MCNUTT, editor-in-chief of the Science family of journals, for election as president of the academy, to succeed Ralph Cicerone when his second term as NAS president ends on July 1, 2016.
CAROLYN BRITTEN was named director of the Hematology/Oncology Division at the Medical University of South Carolina. She will continue her role as associate director for clinical investigations at the MUSC Hollings Cancer Center.
The Oncology Research Information Exchange Network July 9 announced the addition of three cancer institutions to its precision cancer research partnership, bring the total number of partners to nine.
The U.S. House of Representatives July 10 passed H.R. 6, The 21st Century Cures Act without amendments by a 344 to 77 vote.
Three cancer centers have been awarded comprehensive status from NCI, the highest designation possible: the Huntsman Cancer Institute at the University of Utah, UT Southwestern's Harold C. Simmons Cancer Center, and the University of New Mexico Cancer Center.
FDA has often asked ODAC members to discuss broad scientific questions. However, the approval questions have, without an exception, been shoehorned into the up-or-down dichotomy.
The FDA Oncologic Drugs Advisory Committee July 9 appears to have recommended approval for the Eli Lilly and Co. agent necitumumab.Yes, the word “appears” has indeed appeared in the previous sentence.
Proton Partners International Ltd. acquired the site for the first high energy proton beam therapy cancer treatment center will be built in the U.K.
